Fulgent Genetics Inc

FLGT

Company Profile

  • Business description

    Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

  • Contact

    4399 Santa Anita Avenue
    El MonteCA91731
    USA

    T: +1 626 350-0537

    E: [email protected]

    https://www.fulgentgenetics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    1,315

Stocks News & Analysis

stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.
stocks

Turnaround progressing for ASX share

Margins have rebased by shares are undervalued.
stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,735.4083.10-0.94%
CAC 407,987.490.000.00%
DAX 4024,307.92357.351.49%
Dow JONES (US)49,686.12159.950.32%
FTSE 10010,323.75128.381.26%
HKSE25,675.18287.55-1.11%
NASDAQ26,090.73134.41-0.51%
Nikkei 22560,815.95593.34-0.97%
NZX 50 Index12,826.0763.150.49%
S&P 5007,403.055.45-0.07%
S&P/ASX 2008,505.3072.60-0.85%
SSE Composite Index4,131.533.86-0.09%

Market Movers